The End of Life Liberty Project, a project of CascadiaNow!, in partnership with the Drug Policy Alliance, presents a symposium on the exciting new developments in psychedelic medicine, with a focus on efficacy in reducing anxiety in terminally ill patients. This symposium will be held at the University of Washington in Seattle, sponsored by the School of Law.
DETAILS: Exciting new research is revealing that psychedelic drugs, such as psilocybin and MDMA, may offer significant benefit for patients struggling at the end of life and those beset by major depressions and treatment-resistant post-traumatic stress.
This conference brings together doctors, scientific researchers, attorneys and ethicists to consider the medical, legal and ethical implications of this evolving research.
Confirmed speakers include:
- Dan Abrahamson, Senior Legal Advisor, Drug Policy Alliance's Office of Legal Affairs, Oakland, CA
- Ira Byock, M.D., Founder and Chief Medical Officer, Providence Institute for Human Caring, Torrance, CA
- Rick Doblin, Founder and Executive Director of Multidisciplinary Association for Psychedelic Studies, Boston, MA
- Representative Roger Goodman, Washington State Legislature, Kirkland, WA
- Sam Kamin, marijuana law reform expert and Slate series author of “Altered States: Inside Colorado’s Marijuana Economy,” Professor of Law, University of Denver, Denver, CO
- Patricia Kuszler, Charles I. Stone Professor of Law, University of Washington School of Law, Seattle, WA
- Don Lattin, award-winning author and journalist, author of Changing our Minds—Psychedelic Sacraments and the New Psychotherapy, adjunct faculty, Graduate School of Journalism, University of California at Berkeley, CA
- Lynn Mehler, partner, Hogan Lovells, Pharmaceutical and Biotechnology practice, Washington, DC
- Leanna Standish, Ph.D., School of Naturopathic Medicine, Bastyr University, Seattle, WA
- Kathryn Tucker, Executive Director, End of Life Liberty Project
October 27, 2017
8:30 AM - 5:00 PM
William H. Gates Hall
$275.00Standard General (after September 10, 2017)
$225.00Early General (by September 10, 2017)
$175.00Standard Non-Profit & Government (after September 10, 2017)
$125.00Early Non-Profit & Government (by September 10, 2017)